All Novartis articles – Page 3
-
Business
Novartis to shut Horsham site
UK research centre closure to result in the loss of 371 jobs as firm consolidates its global R&D base
-
Business
Japan confirms Novartis clinical trial data fabrication
Investigation into blood pressure blockbuster continues
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
Business
US sues Novartis over alleged kickbacks
Company fraudulently paid pharmacies to switch patients onto its drugs, government claims
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug
-
Business
Vasella to leave Novartis in August
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
-
Business
Novartis biotech plant for Singapore
Firm will invest $500 million in biotech manafacturing
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
- Previous Page
- Page1
- Page2
- Page3
- Next Page